Literature DB >> 19055867

Sickle cell disease in a carrier with pyruvate kinase deficiency.

Nazeer Alli1, Marius Coetzee, Vernon Louw, Ben van Rensburg, Gerrit Rossouw, Lisa Thompson, Serge Pissard, Swee Lay Thein.   

Abstract

We report a case of sickle cell disease (SCD) in a patient who is a carrier for the sickle mutation with no additional mutations in the beta globin genes. Sequencing of the PK-LR genes showed that she was also heterozygous for the L272V mutation in exon 7, which is known to cause pyruvate kinase (PK) deficiency. It appeared that sickling in the heterozygous state is related to decreased oxygen affinity associated with PK deficiency in this unusual case.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055867     DOI: 10.1179/102453308X343536

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  8 in total

Review 1.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

2.  Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.

Authors:  Zenaide M N Quezado; Sayuri Kamimura; Meghann Smith; Xunde Wang; Michael R Heaven; Sirsendu Jana; Sebastian Vogel; Patricia Zerfas; Christian A Combs; Luis E F Almeida; Quan Li; Martha Quezado; Iren Horkayne-Szakaly; Penelope A Kosinski; Shaoxia Yu; Unnati Kapadnis; Charles Kung; Lenny Dang; Paul Wakim; William A Eaton; Abdu I Alayash; Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2022-03-12       Impact factor: 2.372

3.  Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.

Authors:  Minke A E Rab; Jennifer Bos; Brigitte A van Oirschot; Stephanie van Straaten; Penelope A Kosinski; Victor Chubukov; Hyeryun Kim; Heidi Mangus; Roger E G Schutgens; Gerard Pasterkamp; Lenny Dang; Charles Kung; Eduard J van Beers; Richard van Wijk
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

Review 4.  The carrier state for sickle cell disease is not completely harmless.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

Review 5.  Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.

Authors:  Dina Alramadhani; Anfal S Aljahdali; Osheiza Abdulmalik; B Daniel Pierce; Martin K Safo
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

6.  PRPS polymerization influences lens fiber organization in zebrafish.

Authors:  Kyle Begovich; Deborah Yelon; James E Wilhelm
Journal:  Dev Dyn       Date:  2020-04-14       Impact factor: 3.780

Review 7.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

8.  Genetic variants of PKLR are associated with acute pain in sickle cell disease.

Authors:  Xunde Wang; Kate Gardner; Mickias B Tegegn; Clifton L Dalgard; Camille Alba; Stephan Menzel; Hamel Patel; Mehdi Pirooznia; Yi-Ping Fu; Fayaz T Seifuddin; Swee Lay Thein
Journal:  Blood Adv       Date:  2022-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.